SGTX · Categories · Form 4

SGTX - SEC Form 4 insider transactions

Sigilon Therapeutics Inc. (SGTX) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for SGTX

• 1029d
  SEC Form 4 filed by Flagship Ventures Fund V General Partner Llc

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1030d
  SEC Form 4: Eli Lilly & Co bought $25,639,916 worth of shares (1,718,493 units at $14.92)

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1033d
  SEC Form 4 filed by Oesterle Stephen N.

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1033d
  SEC Form 4 filed by Cole Douglas G.

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1033d
  SEC Form 4: Cox John returned 341 shares to the company, closing all direct ownership in the company

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1033d
  SEC Form 4 filed by Shaff Eric D.

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1033d
  SEC Form 4: Yuan Qing Sarah returned 2,884 shares to the company, closing all direct ownership in the company

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1033d
  SEC Form 4: Kowalsky Matthew Paul returned 1,925 shares to the company, closing all direct ownership in the company

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1033d
  SEC Form 4 filed by Ashton-Rickardt Philip

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1033d
  SEC Form 4 filed by Patel Kavita

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1033d
  SEC Form 4 filed by Ruffolo Robert R

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1033d
  SEC Form 4: Vivaldi Coelho Rogerio returned 12,169 shares to the company, closing all direct ownership in the company

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1033d
  SEC Form 4: Pontes Josias returned 3,504 shares to the company, closing all direct ownership in the company

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1048d
  SEC Form 4 filed by Yuan Qing Sarah

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1051d
  SEC Form 4 filed by Pontes Josias

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1051d
  SEC Form 4 filed by Vivaldi Coelho Rogerio

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1114d
  SEC Form 4 filed by Oesterle Stephen N.

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1114d
  SEC Form 4 filed by Ruffolo Robert R

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1114d
  SEC Form 4 filed by Shaff Eric D.

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1114d
  SEC Form 4 filed by Cox John

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1114d
  SEC Form 4 filed by Patel Kavita

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1114d
  SEC Form 4 filed by Cole Douglas G.

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1196d
  SEC Form 4 filed by Kowalsky Matthew Paul

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1196d
  SEC Form 4 filed by Vivaldi Coelho Rogerio

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1196d
  SEC Form 4 filed by Pontes Josias

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1196d
  SEC Form 4 filed by Ashton-Rickardt Philip

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1196d
  SEC Form 4 filed by Yuan Qing Sarah

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1474d
  SEC Form 4 filed by Story Brooke

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1474d
  SEC Form 4 filed by Patel Kavita

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1474d
  SEC Form 4 filed by Oesterle Stephen N.

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1474d
  SEC Form 4 filed by Shaff Eric D.

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1474d
  SEC Form 4 filed by Ruffolo Robert R

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1527d
  SEC Form 4 filed by Yuan Qing Sarah

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1568d
  SEC Form 4 filed by Ashton-Rickardt Philip

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1568d
  SEC Form 4 filed by Vivaldi Coelho Rogerio

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1568d
  SEC Form 4 filed by Pontes Josias

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1568d
  SEC Form 4 filed by Orfali May

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1617d
  SEC Form 4 filed by Ashton-Rickardt Philip

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1617d
  SEC Form 4 filed by Orfali May

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1617d
  SEC Form 4 filed by Vivaldi Coelho Rogerio

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1617d
  SEC Form 4 filed by Pontes Josias

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1651d
  SEC Form 4 filed by Orfali May

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1677d
  SEC Form 4: Vivaldi Coelho Rogerio was granted 50,000 shares, increasing direct ownership by 213% to 73,461 units

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1709d
  SEC Form 4: Pontes Josias was granted 11,500 shares, increasing direct ownership by 625% to 13,339 units

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1803d
  SEC Form 4: RUFFOLO ROBERT R exercised 6,750 units of Common Stock at a strike of $0.57 and sold $69,930 worth of Common Stock (6,750 units at $10.36)

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1808d
  SEC Form 4 filed by Cole Douglas G.

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1808d
  SEC Form 4 filed by Shaff Eric D.

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1808d
  SEC Form 4 filed by Cox John

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1808d
  SEC Form 4 filed by Patel Kavita

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1808d
  SEC Form 4 filed by RUFFOLO ROBERT R

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1808d
  SEC Form 4 filed by Oesterle Stephen N.

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1819d
  SEC Form 4 filed by Story Brooke

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1831d
  SEC Form 4: ANDERSON DANIEL GRIFFITH sold $2,000,000 worth of Common Stock (200,000 units at $10.00), decreasing direct ownership by 9% to 2,022,222 units

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1940d
  SEC Form 4 filed by Devyn Smith

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1940d
  SEC Form 4 filed by Deya Corzo

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1940d
  SEC Form 4 filed by Glenn Reicin

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)
• 1940d
  SEC Form 4 filed by Rogerio Coelho Vivaldi

  4 - Sigilon Therapeutics, Inc. (0001821323) (Issuer)

Other SGTX categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends